-
Glass Malling heeft een update geplaatst 2 dagen, 14 uren geleden
Hydrogels composed of GelMA, incorporating silver and varying mass fractions of GelMA, presented diverse pore sizes and interconnectivity. The pore size of the 10% final mass fraction silver-containing GelMA hydrogel was demonstrably larger than that of the 15% and 20% final mass fraction silver-containing GelMA hydrogels, with both P-values falling below 0.005. A relatively consistent pattern was observed in the in vitro release of nano silver from the silver-infused GelMA hydrogel on treatment days 1, 3, and 7. On the 14th day of treatment, the concentration of released nano-silver in the in vitro environment experienced a sharp rise. After 24 hours of culture, the diameters of the zones of inhibition in GelMA hydrogels with varying nano-silver concentrations (0, 25, 50, and 100 mg/L) were 0, 0, 7, and 21 mm for Staphylococcus aureus, and 0, 14, 32, and 33 mm for Escherichia coli. At 48 hours of culture, the Fbs cell proliferation rates in the 2 mg/L nano silver and 5 mg/L nano silver groups were both significantly higher than those in the control group (P<0.005). On culture days 3 and 7, the proliferation rate of ASCs in the 3D bioprinting group was considerably higher than in the non-printing group, with t-values of 2150 and 1295, respectively, and P values less than 0.05. The 3D bioprinting group on Culture Day 1 exhibited a slightly elevated death rate of ASCs compared to the non-printing group. Culture days 3 and 5 saw a high percentage of live ASCs in both the 3D bioprinting and the non-bioprinting groups. PID 4 rats treated with hydrogel alone or hydrogel combined with nano slivers showed increased exudation, whereas rats receiving hydrogel scaffold/nano sliver or hydrogel scaffold/nano sliver/ASC treatments exhibited dry wounds, lacking evident infection signs. On PID 7, hydrogel-alone and hydrogel/nano sliver-treated rats’ wounds still showed some exudation, in contrast to the notably dry and scabbed wounds in the hydrogel scaffold/nano sliver and hydrogel scaffold/nano sliver/ASC groups. In the PID 14 study, the hydrogels applied to rat wound sites across all four groups were uniformly dislodged from the wound surface. An area of unhealed wounds, small in size, persisted on PID 21 in the hydrogel-only group. Rats with PID 4 and 7 treated with the hydrogel scaffold/nano sliver/ASC combination displayed a significantly higher wound healing rate compared to those in the other three treatment groups (P < 0.005). Rats subjected to PID 14 and treated with the hydrogel scaffold/nano sliver/ASC combination demonstrated a substantial improvement in wound healing compared to those treated with hydrogel alone or with hydrogel and nano sliver (all P < 0.05). The hydrogel scaffold/nano sliver/ASC group displayed a significantly faster wound healing rate in rats on PID 21, compared to the hydrogel alone group (P<0.005). At postnatal day 7, the hydrogels remained stable on the rat wound surfaces in all four groups; however, on postnatal day 14, hydrogel separation was noted in the hydrogel-alone group, whilst hydrogel-containing tissue was still present in the wounds of the three remaining groups. The wounds of rats treated with hydrogel alone on PID 21 demonstrated a disorderly arrangement of collagen, while the wounds of rats treated with hydrogel/nano sliver and hydrogel scaffold/nano sliver/ASC exhibited a more ordered collagen arrangement. GelMA hydrogel containing silver demonstrates remarkable biocompatibility and effective antibacterial action. In rat models with full-thickness skin defects, a three-dimensional double-layer bioprinted structure effectively integrates with the developing tissue, leading to improved wound healing.
The objective is to create a quantitative software for evaluating the three-dimensional morphology of pathological scars, based on photo modeling, and subsequently validate its accuracy and practicality within clinical settings. The study utilized a method of prospective observation as its core. Between the start of April 2019 and January 2022, 59 patients harboring 107 pathological scars, all fulfilling the inclusion criteria, were admitted to the First Medical Center of the Chinese People’s Liberation Army General Hospital. The breakdown of these patients included 27 males and 32 females, with ages ranging from 26 to 44 years, averaging 33 years. Through photo modeling, a software platform for quantifying three-dimensional pathological scar parameters was developed. Its functions include patient data gathering, scar imaging, 3D reconstruction, model browsing, and generating informative reports. Employing this software and clinical techniques (vernier calipers, color Doppler ultrasonic diagnostic equipment, and elastomeric impression water injection method), the longest length, maximum thickness, and volume of the scars were ascertained, respectively. Measurements of successfully modeled scars included the count, distribution, number of patients treated, maximal length, maximum thickness, and total volume of scars, assessed using both software and clinical procedures. To characterize failed modeling scars, the quantity, arrangement, classification, and the number of affected patients were assessed and cataloged. To evaluate the concordance between software and clinical procedures for quantifying scar length, maximum thickness, and volume, unpaired linear regression and the Bland-Altman analysis were performed. The intraclass correlation coefficients (ICCs), mean absolute errors (MAEs), and mean absolute percentage errors (MAPEs) were then calculated. The modeling process successfully replicated 102 scars from 54 patients, these scars being primarily situated within the chest (43), shoulder and back (27), limbs (12), face and neck (9), ear (6), and abdominal region (5). Using both software and clinical techniques, the longest length, maximum thickness, and volume were determined to be 361 (213, 519) cm and 353 (202, 511) cm, 045 (028, 070) cm and 043 (024, 072) cm, and 117 (043, 357) mL and 096 (036, 326) mL respectively. The modeling of 5 patients’ 5 hypertrophic scars and auricular keloids was unsuccessful. The software and clinical methods produced linear correlations for longest length, maximum thickness, and volume, with correlation coefficients of 0.985, 0.917, and 0.998, respectively, and significance levels (p<0.005). According to software and clinical methodologies, the ICCs for the longest, thickest, and largest scars were 0.993, 0.958, and 0.999, respectively. There was a high degree of concordance between the software’s and clinical assessments of scar length, thickness, and volume. The Bland-Altman approach demonstrated that 392% (4/102) of scars possessing the greatest length, 784% (8/102) of scars exhibiting the maximum thickness, and 882% (9/102) of scars with the largest volume were located outside the 95% concordance limits. Within a 95% confidence interval, 204% (2 out of 98) of scars exhibited a length error exceeding 0.5 cm. The longest scar’s maximum thickness and volume measurements from the software and clinical methods exhibited MAE values of 0.21 cm, 0.10 cm, and 0.24 mL, respectively, while the corresponding MAPE values were 575%, 2121%, and 2480% for the same scar measurements. Utilizing photo-modeling technology, a quantitative evaluation software package for three-dimensional pathological scar morphology facilitates the three-dimensional representation and measurement of morphological characteristics in most cases. In comparison to clinical routine methods, the measurement results displayed a satisfactory degree of consistency, with errors remaining within an acceptable clinical range. Auxiliary application of this software aids in the clinical diagnosis and treatment of pathological scars.
The aim of this study was to examine the expansion principles of directional skin and soft tissue expanders (referred to hereafter as expanders) in abdominal scar repair. For a prospective, self-controlled study, a research approach was used. Twenty patients with abdominal scars, who satisfied the inclusion criteria and were admitted to Zhengzhou First People’s Hospital from January 2018 to December 2020, were randomly selected using a table of random numbers. The group included 5 males and 15 females, with ages ranging from 12 to 51 years (average age 31.12 years), composed of 12 ‘type scar’ patients and 8 ‘type scar’ patients. To initiate the process, a pair or trio of expanders, each with a rated capacity of 300 to 600 milliliters, were placed on the scar’s opposing sides; one, specifically of 500 milliliters, was chosen for follow-up analysis. The water injection treatment, scheduled to last 4 to 6 months, commenced after the removal of the sutures. Following the water injection volume reaching twenty times the expander’s rated capacity, a two-stage procedure ensued, commencing with abdominal scar excision, expander removal, and culminating in local expanded flap transfer repair. The skin surface area at the expansion location was determined for water injection volumes equivalent to 10, 12, 15, 18, and 20 times the expander’s rated capacity. Simultaneously, the skin expansion rate at those same multiples of expansion (10, 12, 15, 18, and 20 times) and the intermediate intervals (10-12, 12-15, 15-18, and 18-20 times) was calculated. bi6727 inhibitor Calculations were performed on the surface area of the repaired skin at 0, 1, 2, 3, 4, 5, and 6 months post-operation, as well as the skin’s shrinkage rate at these intervals, both at specific time points (1, 2, 3, 4, 5, and 6 months post-op) and across defined periods (0-1, 1-2, 2-3, 3-4, 4-5, and 5-6 months post-op). To statistically analyze the data, a repeated measures analysis of variance was employed, followed by the application of a least significant difference t-test post hoc. Results indicated a substantial rise in skin surface area and expansion rate for patient expansion sites when scaled 12, 15, 18, and 20 times from the 10-fold expansion (287622 cm² and 47007%) ((315821), (356128), (384916), (386215) cm², (51706)%, (57206)%, (60406)%, (60506)%, respectively), with statistically significant differences (t-values: 4604, 9038, 15014, 15955, 4511, 8783, 13582, and 11848, respectively; P<0.005).